In-Patient Services

Flourish Research has the facilities, staff experience, and equipment to perform a variety of Early Phase Studies, from First-in-Human to early proof of concept.

Built For Efficiency & Excellence

Our state-of-the-art facilities and dedicated teams are supported by centralized services that streamline every milestone, from study start to recruitment to database close.

Budgets and Contracts Icon

Budgets & Contracts

Regulatory Icon




Training Icon




Capabilities & Experiences





Staff Experience

Douglas Denham, DO

Chief Medical Director

Dr. Denham Has Overseen More Than 100 Phase 1 Studies.
Faisal A. Fakih, MD

Chief Medical Director

Dr. Fakih Has Overseen 20 Phase 1 Studies.
Parke Hedges, MD


Dr. Hedges Has Conducted 20 Phase 1 Studies.
Mark Rosenthal, MD


Dr. Rosenthal Has Overseen 4 Phase 1 Studies.
Barbara Corral, DNP, MSN, MA, FNP-BC

Director Early Phase Services

Dr. Corral Has Conducted More Than 20 Phase 1 Studies.
Steven Schmid, PhD

Senior Director, Lab

Dr. Schmid Has More Than 35 Years Of Experience In Drug Discovery And Development.
Doctors examining xrays and meeting with patients

Complex Inpatient Studies

Case Studies:

  • Challenge: a complex schedule of 6 inpatient days, followed by 8 consecutive days of outpatient visits, with a 56-day washout, and then another 6-days inpatient/8-days outpatient series, with multiple PK and safety timepoints.
    Success: Flourish randomized 33 participants in one month with 88% retention.
  • Challenge: a drug involving considerable potential side effects.
    Success: Flourish randomized 72 participants with an 85% completion rate by preparing participants for potential side effects during informed consent and developing strong patient relationships

Top Enrollers:

  • Flourish is consistently recognized as a top enroller, in healthy and special population studies, including rescue situations
  • Robust prescreening program and special population databases

Early Phase Facilities & Equipment

  • 57 inpatient beds
  • Dedicated, secure overnight facilities
  • Temperature data logging & phone alert system
  • Synchronous Atomic Clocks
  • Backup generators
  • Dietician-planned meals
  • IV infusion dosing/monitoring
  • eDocs, eRegulatory for 24/7 access of data
  • eSource
  • Accommodations for sponsor/CROs for onsite observation of dosing/procedures
  • Limited-access, temperature-controlled drug storage
  • Pharmacy hood
  • Ambient and refrigerated centrifuges
  • Drug & specimen refrigerators
  • -80°C and -20°C freezers
  • ECG, with onsite interpretations
  • EEG Procedures
  • Spirometry
  • Accredited sleep labs
  • YSI machines (Biochemistry Analyzer)
  • Crash Carts

PBMC Onsite Processing

Flourish Research offers in-house PBMC (Peripheral Blood Mononuclear Cell) services to meet client needs for the evaluation of cellular immune function within the clinical trial setting.

  • Onsite processing eliminates the need for sample transport
  • Network-wide SOPs and quality control
  • Four labs supporting 8 sites across the U.S.
  • Deliverable: high-yield, high-viability cryopreserved (PBMC) cells
  • Oversight by PhD PBMC thought leader

Best-in-class facilities and processes:

  • Temperature-controlled labs
  • Isolation using Ficoll/CPT and/or other isolation techniques
  • Class II A2 biosafety cabinets
  • Fluorescent staining & image analysis
  • Two-step cryopreservation process
  • Long-term storage in vapor phase of liquid nitrogen at -135°C

Patient Getting Blood Drawn Doctor doing research
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.